{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Taltobulin",
  "nciThesaurus": {
    "casRegistry": "228266-40-8",
    "chebiId": "",
    "chemicalFormula": "C27H43N3O4",
    "definition": "An analogue of the naturally occurring tripeptide hemiasterlin, with potential antimitotic and antineoplastic activities. Taltobulin binds tubulin in a similar manner as colchicine and inhibits tubulin polymerization. This results in the disruption of the cytoskeleton, ultimately leading to cell cycle arrest in G2/M phase, blockage of cell division and apoptosis.",
    "fdaUniiCode": "J6D6912BXS",
    "identifier": "C75998",
    "preferredName": "Taltobulin",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C67421"
    ],
    "synonyms": [
      "HTI-286",
      "SPA-110",
      "TALTOBULIN",
      "Taltobulin"
    ]
  }
}